• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Lunar's second-quarter sales jump 62%

Article

Lunar is continuing the strong growth trend in revenues it hasbeen experiencing for the last several quarters. The Madison,WI, manufacturer of bone densitometry equipment said that salesfor the second quarter of 1996 (end-December) jumped 62% to

Lunar is continuing the strong growth trend in revenues it hasbeen experiencing for the last several quarters. The Madison,WI, manufacturer of bone densitometry equipment said that salesfor the second quarter of 1996 (end-December) jumped 62% to $16.9million, compared with $10.5 million in the same period last year.

Lunar's growth is primarily due to higher sales of its DPXbone densitometry scanner, especially in the U.S., according topresident Dr. Richard Mazess, who presented the numbers at theHambrecht & Quist Health Care Conference in San Franciscolast week. Sales of Lunar's high-end Expert system also increased,and the company believes it has resolved the component shortagethat has delayed Expert shipments.

Lunar's net income is also strong. The company expects netincome to be at least 24¢ a share after considering the company'srecent three-for-two stock split. That figure includes legal costsof about 3¢ a share related to its settlement of patent litigationwith Hologic (SCAN 10/11/95).

Mazess also announced that Lunar will spin off its Bone CareInternational subsidiary, which conducts early-stage researchon vitamin-D compounds for osteoporosis and other applications.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.